Flow Cytometry Antifungal Susceptibility Testing of Aspergillus fumigatus and Comparison of Mode of Action of Voriconazole vis-à-vis Amphotericin B and Itraconazole

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 11, 2003, Pages 3627-3629

  Ramani, Rama ^a   Gangwar, Madhurama ^a,c   Chaturvedi, Vishnu ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b WADSWORTH CENTER   (United States)

^c PUNJAB AGRICULTURAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLUS FUMIGATUS; CELL SELECTION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; FLOW CYTOMETRY; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; FLOW CYTOMETRY; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

EID: 0242322577     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.11.3627-3629.2003     Document Type: Article

References (17)

1. Anonymous. 2001. Caspofungin (Cancidas) for aspergillosis. Medical Letter on Drugs & Therapeutics 43:58-59.
2. Arikan, S., M. Lozano-Chiu, V. Paetznick, S. Nangia, and J. H. Rex. 1999. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J. Clin. Microbiol. 37:3946-3951.
3. Balajee, S. A., and K. A. Marr. 2002. Conidial viability assay for rapid susceptibility testing of Aspergillus species. J. Clin. Microbiol. 40:2741-2745.
4. Chryssanthou, E. 1997. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole. Scand J. Infect. Dis. 29:509-512.
5. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781-803.
6. Denning, D. W., P. Ribaud, N. Milpied, D. Caillot, R. Herbrecht, E. Thiel, A. Haas, M. Ruhnke, and H. Lode. 2002. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis. 34:563-571.
7. Espinel-Ingroff, A. 2001. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J. Clin. Microbiol. 39:1360-1367.
8. Espinel-Ingroff, A., M. Bartlett, V. Chaturvedi, M. Ghannoum, K. C. Hazen, M. A. Pfaller, M. Rinaldi, and T. J. Walsh. 2001. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. Antimicrob. Agents Chemother. 45:1828-1835.
9. Jahn, B., A. Rampp, C. Dick, A. Jahn, M. Palmer, and S. Bhakdi. 1998. Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell level. Antimicrob. Agents Chemother. 42:2569-2575.
10. Kirk, S. M., S. M. Callister, L. C. L. Lim, and R. F. Schell. 1997. Rapid susceptibility testing of Candida albicans by flow cytometry. J. Clin. Microbiol. 35:358-363.
11. Lass-Florl, C., M. Nagl, C. Speth, H. Ulmer, M. P. Dierich, and R. Wurzner. 2001. Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining. Antimicrob. Agents Chemother. 45:124-128.
12. Marr, K. A., M. Koudadoust, M. Black, and S. A. Balajee. 2001. Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay. Clin. Diagn. Lab. Immunol. 8:1240-1247.
13. Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, J. P. Donnelly, and P. E. Verweij. 2001. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:3402-3408.
14. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of conidium forming filamentous fungi. Proposed standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Ramani, R., and V. Chaturvedi. 2000. Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test. Antimicrob. Agents Chemother. 44:2752-2758.
16. Ramani, R., A. Ramani, and S. J. Wong. 1997. Rapid flow cytometric susceptibility testing of Candida albicans. J. Clin. Microbiol. 35:2320-2324.
17. Rex, J. H., M. A. Pfaller, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, and D. W. Warnock. 2001. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14:643-658.